Fuzzy neural network applied to gene expression profiling for predicting the prognosis of diffuse large B-cell Lymphoma

Tatsuya Ando, Miyuki Suguro, Taizo Hanai, Takeshi Kobayashi, Hiroyuki Honda, Masao Seto

研究成果: ジャーナルへの寄稿記事

43 引用 (Scopus)

抄録

Diffuse large B-cell lymphoma (DLBCL) is the largest category of aggressive lymphomas. Less than 50% of patients can be cured by combination chemotherapy. Microarray technologies have recently shown that the response to chemotherapy reflects the molecular heterogeneity in DLBCL. On the basis of published microarray data, we attempted to develop a long-overdue method for the precise and simple prediction of survival of DLBCL patients. We developed a fuzzy neural network (FNN) model to analyze gene expression profiling data for DLBCL. From data on 5857 genes, this model identified four genes (CD10, AA807551, AA805611 and IRF-4) that could be used to predict prognosis with 93% accuracy. FNNs are powerful tools for extracting significant biological markers affecting prognosis, and are applicable to various kinds of expression profiling data for any malignancy.

元の言語英語
ページ(範囲)1207-1212
ページ数6
ジャーナルJapanese Journal of Cancer Research
93
発行部数11
DOI
出版物ステータス出版済み - 11 1 2002

Fingerprint

Lymphoma, Large B-Cell, Diffuse
Gene Expression Profiling
Neural Networks (Computer)
Combination Drug Therapy
Genes
Lymphoma
Biomarkers
Technology
Drug Therapy
Survival
Neoplasms

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

これを引用

Fuzzy neural network applied to gene expression profiling for predicting the prognosis of diffuse large B-cell Lymphoma. / Ando, Tatsuya; Suguro, Miyuki; Hanai, Taizo; Kobayashi, Takeshi; Honda, Hiroyuki; Seto, Masao.

:: Japanese Journal of Cancer Research, 巻 93, 番号 11, 01.11.2002, p. 1207-1212.

研究成果: ジャーナルへの寄稿記事

Ando, Tatsuya ; Suguro, Miyuki ; Hanai, Taizo ; Kobayashi, Takeshi ; Honda, Hiroyuki ; Seto, Masao. / Fuzzy neural network applied to gene expression profiling for predicting the prognosis of diffuse large B-cell Lymphoma. :: Japanese Journal of Cancer Research. 2002 ; 巻 93, 番号 11. pp. 1207-1212.
@article{f3f37876f79746059c3f7bbea4271167,
title = "Fuzzy neural network applied to gene expression profiling for predicting the prognosis of diffuse large B-cell Lymphoma",
abstract = "Diffuse large B-cell lymphoma (DLBCL) is the largest category of aggressive lymphomas. Less than 50{\%} of patients can be cured by combination chemotherapy. Microarray technologies have recently shown that the response to chemotherapy reflects the molecular heterogeneity in DLBCL. On the basis of published microarray data, we attempted to develop a long-overdue method for the precise and simple prediction of survival of DLBCL patients. We developed a fuzzy neural network (FNN) model to analyze gene expression profiling data for DLBCL. From data on 5857 genes, this model identified four genes (CD10, AA807551, AA805611 and IRF-4) that could be used to predict prognosis with 93{\%} accuracy. FNNs are powerful tools for extracting significant biological markers affecting prognosis, and are applicable to various kinds of expression profiling data for any malignancy.",
author = "Tatsuya Ando and Miyuki Suguro and Taizo Hanai and Takeshi Kobayashi and Hiroyuki Honda and Masao Seto",
year = "2002",
month = "11",
day = "1",
doi = "10.1111/j.1349-7006.2002.tb01225.x",
language = "English",
volume = "93",
pages = "1207--1212",
journal = "Cancer Science",
issn = "1347-9032",
publisher = "Wiley-Blackwell",
number = "11",

}

TY - JOUR

T1 - Fuzzy neural network applied to gene expression profiling for predicting the prognosis of diffuse large B-cell Lymphoma

AU - Ando, Tatsuya

AU - Suguro, Miyuki

AU - Hanai, Taizo

AU - Kobayashi, Takeshi

AU - Honda, Hiroyuki

AU - Seto, Masao

PY - 2002/11/1

Y1 - 2002/11/1

N2 - Diffuse large B-cell lymphoma (DLBCL) is the largest category of aggressive lymphomas. Less than 50% of patients can be cured by combination chemotherapy. Microarray technologies have recently shown that the response to chemotherapy reflects the molecular heterogeneity in DLBCL. On the basis of published microarray data, we attempted to develop a long-overdue method for the precise and simple prediction of survival of DLBCL patients. We developed a fuzzy neural network (FNN) model to analyze gene expression profiling data for DLBCL. From data on 5857 genes, this model identified four genes (CD10, AA807551, AA805611 and IRF-4) that could be used to predict prognosis with 93% accuracy. FNNs are powerful tools for extracting significant biological markers affecting prognosis, and are applicable to various kinds of expression profiling data for any malignancy.

AB - Diffuse large B-cell lymphoma (DLBCL) is the largest category of aggressive lymphomas. Less than 50% of patients can be cured by combination chemotherapy. Microarray technologies have recently shown that the response to chemotherapy reflects the molecular heterogeneity in DLBCL. On the basis of published microarray data, we attempted to develop a long-overdue method for the precise and simple prediction of survival of DLBCL patients. We developed a fuzzy neural network (FNN) model to analyze gene expression profiling data for DLBCL. From data on 5857 genes, this model identified four genes (CD10, AA807551, AA805611 and IRF-4) that could be used to predict prognosis with 93% accuracy. FNNs are powerful tools for extracting significant biological markers affecting prognosis, and are applicable to various kinds of expression profiling data for any malignancy.

UR - http://www.scopus.com/inward/record.url?scp=0036868316&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036868316&partnerID=8YFLogxK

U2 - 10.1111/j.1349-7006.2002.tb01225.x

DO - 10.1111/j.1349-7006.2002.tb01225.x

M3 - Article

VL - 93

SP - 1207

EP - 1212

JO - Cancer Science

JF - Cancer Science

SN - 1347-9032

IS - 11

ER -